Guardant Health, Inc. (GH) Financial Statements
Guardant Health, Inc. (GH) reported trailing twelve-month revenue of $1.2B (up 42.7% year on year) and net income of -$453.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$240.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GHGuardant Health, Inc.Follow GH — free
—
Price chart with a free account
- Market cap
- 22.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.21 | 0.29 | 0.37 | 0.45 | 0.56 | 0.74 | 0.98 | 1.18 | |
| Gross profit | — | — | — | — | 0.34 | 0.45 | 0.63 | 0.77 | |
| Research & development | 0.09 | 0.15 | 0.26 | 0.37 | 0.37 | 0.35 | 0.36 | 0.38 | |
| Operating income | -0.08 | -0.25 | -0.41 | -0.54 | -0.56 | -0.44 | -0.44 | -0.47 | |
| Pre-tax income | -0.07 | -0.25 | -0.38 | -0.65 | -0.48 | -0.44 | -0.42 | -0.45 | |
| Income tax | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | |
| Net income | -0.08 | -0.25 | -0.38 | -0.65 | -0.48 | -0.44 | -0.42 | -0.45 | |
| Diluted EPS ($) | -0.84 | -2.60 | -4.00 | -6.41 | -4.28 | -3.56 | -3.32 | -3.49 | |
| Diluted shares (bn) | — | — | 0.101 | 0.102 | 0.112 | 0.123 | 0.125 | — |
USD billions · SEC XBRL
Guardant Health, Inc. — questions
- What is Guardant Health, Inc.'s revenue?
- $1.2B over the twelve months to 2026-06-30, up 42.7% year on year, from its 10-Q and 10-K filings.
- What is Guardant Health, Inc.'s net income?
- -$453.4M over the twelve months to 2026-06-30.
- What is Guardant Health, Inc.'s free cash flow?
- -$240.7M over the twelve months to 2026-06-30.
- What are Guardant Health, Inc.'s diluted earnings per share?
- $-3.49 over the twelve months to 2026-06-30.
Every figure on this page comes from Guardant Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.